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ABSTRACT
Pouzolzia zeylanica (L.) Benn is one of the medicinal plants that possess a lot of bioactive compounds with potential for
therapeutics. These plants have usually been consumed in traditional way despite its efficacy and safety proven. The objectives
of this study were to evaluate the toxic and pharmacological effects of concentrated and spray-dried extract of Pouzolzia
zeylanica. The plant is popular for its auxiliary substances in the treatment of cough; however, the information about the
safety of their usage need to be explored. In the study, the antibacterial ability of respiratory, acute oral toxicity, effects of
reducing sputa and cough symptom were evaluated. The antibacterial ability of the test product was assessed on 5 strains of
respiratory tract pathogenic bacteria by minimum inhibitory concentration (MIC) method. The acute oral toxicity, effect to
reduce sputum and cough treatment was tested in mice through capsaicin model following standardized methods. It was
observed that both products were not causing acute oral toxicity. Pouzolzia zeylanica spray-dried powder had antibacterial
activity on Streptococcus pyogenes with MIC of 50 mg/mL. Dose, which used (6 g/day converted in humans) showed effect
on reducing sputa and cough symptom due to stimulation of cough model with capsaicin. In contrast, the concentrated product
did not show antimicrobial activity in tested bacterial strains. Dose at 4 g/day converted in humans showed effect on reducing
sputa in experimental mice that were affected with capsaicin. Nevertheless, the effect of it on cough symptoms caused by the
capsaicin model was not typical in comparison with spray dried powder. Result showed that spray-dried powder did not
exhibit acute oral toxicity, had antibacterial properties, reduced sputum and treated cough. This promises that it can be developed
into a convenient instant tea product, supporting good health for consumers in preventing diseases.
Key words: Pouzolzia zeylanica, concentrated and spray-dried products, toxicity, pharmaceutic, experimental
mice
INTRODUCTION
Plants have been used in traditional medicine for
several centuries. From ancient times, people have
been exploring and using various plants and plant
products to cure many different diseases. Several
plants are currently undergoing investigation to
determine their therapeutic efficacy and many plant
species are traditionally used for respiratory illness
treatment. Respiratory diseases can be caused by
several reasons, such as the presence of micro-
organisms or toxins in the environment, which
generally attack weak organisms with nutritional
deficiencies. The most common related respiratory
illness symptoms are tonsillitis, bronchitis,
pneumonia and influenza. The main symptoms of
these disorders are often very similar and are
manifested in the following ways: flushing, cough,
fever, headache and sore throat (Shah et al., 2015).
Many plants are used in phytotherapic
preparations without standard quality control. Some
studies have showed the presence of secondary
metabolites with toxic and carcinogenic potential
when used chronically (Ernest, 2004; Rietjens et al.,
2005). The toxicological studies on effects of
medicinal plants on human health have been
conducted deliberately (Simão et al., 2014).
Pouzolzia zeylanica is a medicinal plant, which
is located in tropical and subtropical regions. It has
been used as one of the components in herbal
remedies for treating various diseases. In Vietnam,
this plant was popularly cultivated in Mekong Delta
region. The plant is commonly used as fresh or dried
plant, decoction drunk to treat cough up phlegm,
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pulmonary tuberculosis, sore throat, enteritis,
dysentery, diuretic, anti-inflammation, urinary
infections, galactopoietic, pulmonary disease, etc
(Vo Van Chi, 2012). In addition, people from many
Asian countries have used it to treat various kinds
of diseases by traditional method such as poultice
to bone fractures (Ratnam & Raju, 2008), boils and
to relieve stomachache (Yusuf et al., 2006), diabetes
(Mondal et al., 2013), cancer (Sandhya et al., 2013),
treat eyes injuries (Purkayastha et al., 2007), itching,
dysentery and loose stools of infant (Bhattacharjya
& Borah, 2008), cure stomach ailments, preventive
radiation and confirmed the therapeutic value of
polyphenols contained in the leaves (Li, 2006). In
modern medicine, Pouzolzia zeylanica is also
combined with other herbs that have ability to fight
cancer cells, against tuberculosis and good effect on
lungs (Le, 2007).
The objectives of this study were to determine
antibacterial ability of respiratory, acute oral
toxicity, effect of reducing sputa and cough
symptom of two products (concentrated and spray-
dried) made from extraction of Pouzolzia zeylanica
plants.
MATERIALS AND METHODS
Preparation of products for test
Pouzolzia zeylanica was collected from
experimental area of An Giang University, Vietnam
in March 2015 and harvested after one and a half
month of cultivation, with 20-30 cm in height. The
whole plant was then cleaned with tap-water,
dehydrated by sun drying until the final moisture
content about 12%, cut into small pieces about
2-3 cm long. The optimal extraction conditions of
dried plants were performed at 81°C for 30 min and
water/material ratio of 27/1 v/w. The hot extract
was filtered through cotton cloth and determined
their volumes. After that, the extract was blended
with citric acid of 0.29%, 20°Brix by sucrose and
0.29% carboxymethyl cellulose; vacuum cooking
at 600 mmHg for 40 min, the final product was
60°Brix (concentrated product). The extracted
compound was blended with 9% maltodextrin and
0.08% arabic gum. Later, spray dried process was
conducted at inlet drying temperature of 179°C,
feed flow rate of 18 rpm, the moisture of obtained
powder was 6.5% (spray-dried product). They were
packaged and stored at room temperature for further
experiments.
Source of experimental organisms
The bacterial strains selected for this study were
Staphylococcus aureus (ATCC12600), Streptoccocus
pyogenes (ATCC12344), Streptococcus pneumoniae
(ATCC27336), Klebsiella pneumoniae (ATCC70063),
Pseudomonas aeruginosa (ATCC9027). These
bacterial strains were stored at Medicine and
Pharmacy University in Ho Chi Minh City, Vietnam.
Male and female white mice, Swiss albino strains,
average weight 20 ± 2 g were provided by Nha Trang
Institute of Vaccines and Medical Biologicals,
Vietnam. Mice were raised with pelleted foods,
drinking water sufficiently and were kept stable for
at least a week before the test.
Experimental designs
Quantify the antibacterial capacity of the product
by the Minimum Inhibitory Concentration method
Experimental bacteria were cultivated on
Mueller Hinton Agar (MHA) medium at 37°C for
24 hr. About 3-4 colonies of bacteria transferred into
a test tube containing 10 mL of Mueller Hinton
Broth (MHB), incubated for 4-6 hr at 37°C until the
absorbance at 625 nm was measured with a cuvette
(1 cm) to reach 0.08-0.10; corresponding to about
108 CFU/mL. This bacterial suspension was diluted
to a density of 107 CFU/mL with sterile buffer
solution. After dilution, the bacteria suspension was
proceed for further testing within 15 min. Two test
products were diluted in MHA medium, which were
melted and allowed to cool to about 50°C.
Accurately weighed 500 mg of the test product was
put into a sterile test tube No.1. Subsequently, about
10 mL MHA was added into the mixture and then
strongly vortexed to mix the mixture well and to
obtain a test product concentration of 50 mg/mL.
Later, approximately 5 mL was taken from tube No.1
and transferred to test tube No.2 containing 5 mL
of MHA medium. serial dilution 1/2 was continued
as above to test tube number 10 to obtain a range
of medium containing diluted test product 1/2
gradually. Test tubes containing MHA was poured
into petri dishes, cooled to solidify. When medium
solidified, about 1 µl of the above prepared bacterial
suspension was streaked onto the surface of all
agar plates. The plates were then incubated at
37°C for 24 hr. The trace of bacteria growing at the
implantation point and MIC was recorded (Patel
et al., 2015).
Oral route toxicity investigation
Male and female white mice were starved for
16 hr and divided into similar groups. Mice in the
same batch would receive the same dose of the
survey. The volume of oral dose was 20 mL/kg of
mouse weight and no more than 0.5 mL/rat/time.
The assessment based on the reactive or
incapacitated (life or death) was found in each
mouse in the group after 72 hr. The mice were
followed up after 14 days of drinking to recognize
abnormal symptoms (if any) (Do, 1996; National
Institute of Medicinal Materials, 2006).
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Survey reducing ability of phlegm
White male mice with Swiss albino strains, 5-6
weeks of age, were randomly divided into 6
experiments group (n = 8-10) as follows: batches of
control (drinking distilled water), test batches 1 and
2 were given drinking concentrated product with
dose equivalent to 1/10 and 1/20 Dmax, test batches
3 and 4 were given drinking spray-dried powder
samples equivalent to 1/10 and 1/20 Dmax and
batches of reference (positive) drinking ambroxol
(capsule Ambroxol ®, containing ambroxol HCl
30 mg, DOMESCO Pharmaceutical Joint Stock
Company (Vietnam), lot number 0050316,
expecting March 5, 2019) dose of 240 mg/kg.
Samples and ambroxol were dissolved in distilled
water and given to mice with an oral volume of
10 ml/kg of mouse weight, continuously for 3 days
and given once a day. One hour after the final drink,
mice were injected with 2.5% phenol red solution
in physiological saline. After 30 min of injection
with phenol red, the mice were euthanized and the
trachea was separated, immediately placed in the test
tube containing 2 mL of physiological saline and
placed in the ultrasonic tank for 15 min. Then 2 mL
of 5% sodium bicarbonate solution was added and
the mixture was measured absorbance at 558 nm.
Expectorant effect was assessed by increasing the
optical density in the test plots or the lot compared
to the control batch by the formula: Percentage of
phenol red secretion (%) = [(Dt – D0)/D0 x 100)],
where Dt is the optical density measured in the test
lot, Do is the optical density measured in the control
lot (Engler & Szelenyi, 1984; Dapaah et al., 2016).
Investigation of cough suppressant effects
White male mice with Swiss albino strains, 5-6
weeks of age, were randomly divided into 6
experiments group (n = 8-10) as follows: batches of
control (drinking distilled water), test batches 1 and
2 were given drinking concentraed product with
equivalent to 1/10 and 1/20 Dmax, batches 3 and
4 were given drinking spray dried powder sample
with doses equivalent to 1/10 and 1/20 Dmax and
comparison batches (positive) Neo-codion® tablets
(film tablets containing codeine camphosulfonate
25 mg equivalent to codeine 14.93 mg, sulfogaiacol
100 mg and 20 mg Grindélia extract) dose of
1 tablet/kg. The test and positive samples were
dissolved in distilled water and given to the mice
orally at dose of 10 mL/kg of mouse weight once
daily for 3 days. Two hours after the last drink, mice
were placed in glass jars (similar in size to
desiccators, vented) and exposed to capsaicin
(Sigma-Aldrich, USA, mixed in ethanol 10%
+Tween-80 10%) aerosol form at a concentration
of 100 mM for 10 min with an injection volume of
0.25 mL/min. The potential for cough, number of
coughs and behavioral symptoms of the mouse
(sniffing-scratching the muzzle, jumping up by
strong stimulation) for 10 min were identified.
Later, mice trachea were separated and the phenol
red assay was performed similar as content of survey
reducing ability of phlegm (Nieto et al., 2003;
Tanaka & Maruyama, 2005; Canning, 2008; Zhang
et al., 2009; Satia et al., 2017).
Statistical analysis
The results obtained in the tests are indicated
by the average (Mean ± SEM) of replication (n = 8-
10) and statistical analysis of data based on the T-
test or One-way ANOVA tests followed by Student-
Newman test- Keuls, with 95% reliability (p<0.05)
with SigmaStat® ver software. 3.5 (SYSTAT
Software Inc., Richmond, CA, USA).
RESULTS AND DISCUSSION
The antibacterial capacity of two test products
Survey of antimicrobial activity of medicinal
plants can be used in many different assessment
methods. But the method of minimum inhibitory
concentration (MIC) and agar well diffusion (AWD)
are the two most commonly used methods
(Anyanwu & Okoye, 2017). MIC assessment is a
quantitative method of measuring antibacterial
activity based on the principle of contact between
bacteria with a range of different diluted test
substances concentrations. MIC is the lowest
concentration of antimicrobial substances that
prevent bacterial growth under known conditions
(Nasir et al., 2015). AWD method is used because it
is possible to indicate plant extract concentration
that affects the structural and functional morphology
of the test bacteria, based on the principle of contact
between test bacteria and equal volume of test
substances. Each of the test substances had different
concentrations pumped into wells of equal depth on
agar medium. Differences in the data collected using
MIC assessment may be influenced by factors
such as the concentration of the test substance, the
type of development medium of bacterium, the
incubation time and the method of preparation of
the test substance (Balouiri et al., 2016).
Test results of samples diluted with a
concentration from 50 to 0.1 mg/mL on bacterial
strains in Table 1 showed that most of the bacteria
were not inhibited (–) at the concentrations used,
except for Streptococcus pyrogenes (+) at the
concentration of spray dried powder 50 mg/mL
(Figure 1). This could be explained as the survey
concentration of the sample was not enough to
inhibit bacteria because both spray dried and
concentrated products made from aqueous extract,
concentration of bioactive compounds in the
product was relatively low.
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Table 1. The results determine the antibacterial activity of two test samples
Bacterial strains Control
                        Concentrate product (mg/mL)
50 25 12.5 6.25 3.13 1.56 0.78 0.39 0.20 0.10
S. aureus – – – – – – – – – – –
S. pyogenes – – – – – – – – – – –
S. pneumoniae – – – – – – – – – – –
K. pneumoniae – – – – – – – – – – –
P. aeruginosa – – – – – – – – – – –
Bacterial strains Control
           Spray-dried powder (mg/mL)
50 25 12.5 6.25 3.13 1.56 0.78 0.39 0.20 0.10
S. aureus – – – – – – – – – – –
S. pyogenes – + – – – – – – – – –
S. pneumoniae – – – – – – – – – – –
K. pneumoniae – – – – – – – – – – –
P. aeruginosa – – – – – – – – – – –
Note: (–) no antimicrobial activity; (+) shows antibacterial activity.
Fig. 1. Antibacterial test samples by MIC method.
In reported studies, the low concentration of
the test sample could inhibit the activity of bacteria.
Foe example aqueous extract from leaves of
Amaranthus hybridus with MIC of 6.33 mg/mL
(Nduche et al., 2016); and methanol and ethanol
extract of Allium ascalonicum, Terminalia
glaucescens, Allium cepa, and ethanol extract of
Securidaca longepedunculata with MIC of 50 mg/
mL (Adeleye et al., 2008). Research of Bello et al.
(2011) showed aqueous extract from Pavetta
crassipes with antibacterial activity of P.
aeruginosa, S. pyogenes, K. pneumoniae and N.
gonorrhoeae with MIC from 6.25–12.5 mg/mL.
Antimicrobial activity (P. aeruginosa, S. aureus, E.
coli, K. pneumoniae) and mold (A. niger, C.
albicans) of ethanol extract from C. alata Linn
(Leguminosae) seed had the inhibitory con-
centration of 6.25–50 mg/mL (Okwu & Nnamdi,
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2011). The methanol extract from G. latifolium
leaves had an inhibitory MIC of P. monteilli of
75 mg/mL (Ikegbunam et al., 2014). The ethanol
extract of Evolvulus alsinoides had MIC from 16
mg/mL to 512.5 mg/mL; lowest in S. typhi and
highest in B. cereus and S. aureus (Omogbai &
Eze, 2011). Extracts from Uritca dioica at a
concentration of 100 mg/mL showed antimicrobial
activity but no antifungal activity (Modarresi-
Chahardehi et al., 2012). Minimum inhibitory
concentration values of plant extracts inhibit
bacteria with different concentrations depending on
the kind of various plants, the solvent used and the
test strain (Van-Vuuren, 2015).
The results in Tables 1 and 2 showed that the
spray-dried powder sample with MIC on the
Streptoccocus pyogenes strain was 50 mg/mL. The
test samples did not exhibit antimicrobial activity
on other bacterial strains.
Oral route toxicity of two test products
After 72 hr of testing, the maximum
recommended dose of the test sample (concentrated
product) on white mice was 20 g/kg of mouse
weight, with a death rate of 0% and LD50 could not
be determined. Therefore, the highest dose mouse
can drink without causing the death (Dmax), Dmax =
20 g/kg body weight of mouse could be determined.
The maximum dose of the test sample (spray dried
powder) on white mice was 30.12 g/kg of mouse
weight, with a death rate of 0% and could not be
determined LD50. Therefore, Dmax = 30.12 g/kg of
mouse weight could be determined.
Test samples (concentrated product and spray-
drying powder) did not exhibit oral acute toxicity
on white mice; all mice were still eating and living
normally during 72 hr of observation. Mice were
followed up after 14 days of drinking and abnormal
symptoms were not noticed. The results of general
anatomy of internal organs of liver, heart, lungs,
stomach, kidneys showed no abnormal signs (Table
4). Based on the results of the oral toxicity
assessment, the safe therapeutic dose range for
pharmacological tests was determined (Table 3).
Reducing ability of phlegm of two test products
The ambroxol is a metabolite product which has
active bromhexine, acts to destroy mucus that
accumulates in the bronchial wall and increase their
excretion through the active function of villi.
Ambroxol alters the structure of bronchial secretions
by reducing and cutting mucopolysaccharide fibers,
reducing synthesis sulfomucin of cells, so the
phlegm spitting becomes easier. The concentrated
product (dose of 1.0 g/kg) and spray-dried powder
from the Pouzolzia zeylanica extract (dose of 1.5
g/kg) all showed the effect of increasing the red
phenol secretion in the white mouse trachea,
reaching statistical significance (p<0.05) compared
to the control group and similar to the effect of
ambroxol (Table 5). In high concentration of
concentrated product (2.0 g/kg) and spray-dried
powder (3.0 g/kg) from the Pouzolzia zeylanica
extract did not show the effect of increasing phenol
red secretion in the white mice trachea (p>0.05).
It might be due to reverse inhibitory reaction.
Therefore, dose of 1.0 g/kg and 1.5 g/kg of test
samples were selected for the study of the effect of
two Pouzolzia zeylanica products on capsaicin
cough models.
Besides, results in Table 5 showed that
capsaicin reduces phenol red secretion in the white
mice trachea of the untreated group (capsaicin
control group), achieving statistical significance
compared to the physiological control group. Neo-
codion® drugs increased phenol red secretion of
mice trachea that caused cough with capsaicin, with
increasing 54,55% and statistical significance
compared to the batch of capsaicin, indicating the
effect of reducing phlegm. The ingredients in Neo-
Table 2. MIC of two test samples in survey condition
Baterial strains
                                             MIC (mg/mL)
Concentrate product Spray-dried powder
Staphyloccocus aureus – –
Streptoccocus pyogenes – 50
Streptoccocus pneumoniae – –
Klebsiella pneumoniae – –
Pseudomonas aeruginosa – –
Note: (–) not determine activity.
Table 3. Dose selected for pharmacological tests
Test samples
                          Dose (g/kg)
1/10 Dmax 1/20 Dmax
Concentrate product 2.0 1.0
Spray-dried powder 3.0 1.5
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Table 5. The evaluation result of percent ratio increased the phenol red secretion of normal mice group and mice group
caused cough using a capsaicin model





Distilled water control – 0.083 ± 0.005 – –
Ambroxol 0.24 0.166 ± 0.027 0.004 99.70
Concentrate product 1.0 0.150 ± 0.021 0.026 80.96
2.0 0.102 ± 0.013 0.409 23.01
Spray-dried powder 1.5 0.164 ± 0.022 0.008 97.47
3.0 0.102 ± 0.014 0.682 22.13





Physiological control – 0.086 ± 0.004 – –
Capsaicin control – 0.060 ± 0.007 0.008* ↓ 30.27
Neo-codion® 1 tablet/kg 0.093 ± 0.010 0.016# ↑ 54.55
Concentrate product 1.0 0.093 ± 0.013 0.043# ↑ 55.29
Spray-dried powder 1.5 0.099 ± 0.010 0.006# ↑ 65.68
Notes: *: compare with physiological control; #: compare with pathological control.
Table 4. Results of assessing the behavior of mice in the 14 days of survey after drinking the test samples in maximum
dose Dmax
Organ systems Observe and test General signs
Central nervous system and Behavior, movement Mouse movement and normal eating activities
movement nervous system in the cage. Do not record states of agitation or
loss of reflexes, sleep, or coma
Vegetative nervous system Brain and spinal cord reactions No abnormal expression
Muscle strength Normal
Eye-nose Normal
Respiratory system Characteristics and speed Normal breathing, not recognized symptoms of
dyspnea or convulsions trachea
Cardiovascular system Cardiovascular signs Not noted abnormalities in heart rhythm
Stomach, intestines The symptoms Not recognized symptoms of diarrhea,
constipation.
Abdominal shape Not recognized symptoms of abdominal twists
Stiffness and color of stool Normal mouse droppings.
Genital Penis Pinky and puffed up
Skin and fur Color, status Silky white hair. No redness symptoms on the
skin or ruffling
General condition Weight gain In normal physiological threshold
codion® formula all work to treat coughs. Codeine
is an alkaloid of opium fruit, an anti-cough drug
which was effective on central nerous system and
inhibition of respiratory center. Sulfogaiacol has
the effect of secretions dilution in the respiratory
mucosa and had effect on reducing phlegm. Ethanol
extract Grindélia has anti-cough effect. Concentrated
product (dose of 1.0 g/kg) and spray-dried powder
(dose of 1.5 g/kg) all showed the effect of increasing
red phenol secretion in the trachea of white mice
caused by capsaicin, with an increase of 55.29% and
65.68%, reaching statistical significance compared
to the batch of capsaicin and not significantly
different from the physiological control group. The
effect of reducing phlegm of the samples of
Pouzolzia zeylanica is similar to the effect of Neo-
codion®.
COUGH TREATMENT OF PRODUCTS PRODUCED FROM Pouzolzia zeylanica PLANTS 49
Cough suppressant effects of two test products
Capsaicin (8-methyl-N-vanillyl-6-nonenamide),
a spicy ingredient in chilli, has long been used to
stimulate coughing in a safe way, depending on the
dosage used to show different levels of cough, this
can reflect the reaction of nerve fibers (C-fiber) in
the lining of the respiratory tract. The results in
Table 6 have shown that powder sample (1.5 g/kg
dose) prolonged the occurrence of cough symptoms
in mice groups, which caused cough using capsaicin
model, significantly different from the batch of
control capsaicin. The occurrence time of cough
symptoms in mice group using Neo-codion® or
concentrated product (dose of 1 g/kg) was not
statistically significant difference (p>0.05)
compared to the capsaicin control group.
The results in Table 7 showed that Neo-
codion® drug reduced the number of sneezing and
brushing feather at the muzzle of mice using
capsaicin model, which was statistically different
from the batch of control capsaicin. But the number
of sneezing and combing feather at the muzzle of
mice drinking concentrated product (dose of 1 g/kg)
or spray-dried powder (dose of 1.5 g/kg) had a
reduced, which did not reach statistical significance
compared to the control capsaicin experimental
group.
The results in Table 8 also showed that the
spray-dried powder (1.5 g/kg dose) had similar effect
of Neo-codion® drug reduced the number of jumps
due to stimulation caused using capsaicin coughing
model, statistically significant difference from the
batch of control capsaicin. However, the number
of jumps due to stimulation in rats taking
concentrated product (dose of 1 g/kg) was not
statistically significantly from the control capsaicin
experimental group.
CONCLUSION
The two tested products did not exhibit oral tract
acute toxicity when evaluated in white mice. At
the same time, the two products did not have
antibacterial activity against the 5 selected strains
of bacteria (Staphylococcus aureus, Streptoccocus
pyogenes, Streptococcus pneumoniae, Klebsiella
pneumoniae, Pseudomonas aeruginosa), which were
related with diseases of respiratory tract except,
spray-dried powder.
The spray-dried powder had antibacterial
activity on strains of Streptococcus pyogenes with
a minimum inhibitory concentration (MIC) of
50 mg/mL; at dose of 6 g/day converted in humans,
Table 6. The evaluation result of the time that appear cough symptoms of mice group caused
cough using a capsaicin model
Experimental group (n = 8) Oral dose (g/kg) Time (seconds) p-value
Capsaicin control 1.63 ± 0.26 –
Neo-codion® 1 tablet/kg 1.75 ± 0.25 0.736
Concentrate product 1.0 2.38 ± 0.26 0.063
Spray-dried powder 1.5 2.88 ± 0.52 0.049
Table 8. The evaluation result of the number jumps due to stimulation of mice group caused
cough using a capsaicin model
Experimental group (n = 8) Oral dose (g/kg) Number of jumps p-value
Capsaicin control 21.38 ± 4.02 –
Neo-codion® 1 tablet/kg 10.13 ± 2.89 0.039
Concentrate product 1.0 12.0 ± 3.53 0.101
Spray-dried powder 1.5 9.25 ± 3.10 0.032
Table 7. The evaluation result of the number sneezing and brushing feather at muzzle of
mice group caused cough using a capsaicin model
Experimental group (n = 8) Oral dose (g/kg) Times number p-value
Capsaicin control 126.0 ± 13.90 –
Neo-codion® 1 viên/kg 78.75 ± 5.44 0.007
Concentrate product 1.0 102.38 ± 9.25 0.179
Spray-dried powder 1.5 115.13 ± 13.11 0.578
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it had effect on reducing sputa and cough symptom
due to stimulation of cough model with capsaicin.
The concentrated product did not show
antimicrobial activity in bacterial strains related
with respiratory tract disease; at a dose of 4 g/day
converted in humans, it had effect on reducing sputa
in experimental mice affected with capsaicin, but
the effect of it on cough symptoms caused by the
capsaicin model was not typical in comparison with
spray-dried powder.
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